Growth-oriented stocks have been falling throughout the first half of the year, but now they appear to be reversing and Goldman Sachs has its eye on some names that could be set to thrive in the next bull run. A spike in Treasury yields at the start of the year sent growth stocks lower at first. Rising rates make future profits, like those promised by growth companies, less attractive. However, stocks appear to have found a bottom in June and are inching higher with investors embracing the idea that inflation has peaked and the Federal Reserve could slow the pace of interest rate hikes. capacity. However, many investors continue to speculate on the possibility that the stock will fall back before a meaningful reversal. The tech-heavy Nasdaq Composite was up 12.4% in July, but still down 20% for the year and 21% below the record. For others looking for opportunities on the way back, Goldman Sachs highlighted a few. All of them are expected to see sales growth of more than 20% this year and next, as well as strong earnings in the fourth quarter of 2022. They are also cheap, based on the business’s value-to-revenue ratio. Here are 10 stocks: Information technology and healthcare stocks dominate the list. Lyft is one of the largest stocks by market capitalization on the list. It’s down about 53% on the year but expects sales growth of 32% this year. It has the lowest corporate-to-revenue value ratio of the stocks on the list at 0.9. On the other hand, the health company OptimizeRx has a high business value-to-sales ratio at 3.9. It is down 72.7% for the year. Car comparison website CarGurus is forecast to grow sales 119% this year and 37.7% in 2023. It is down 29% on the year. Riot Blockchain, the bitcoin mining company, has an EV/sales ratio of 1.5. It is expected to increase sales this year by 54.3%. Vital Farms, Cano Health, Zynex, Rover Group, PubMatic and NeoGames are also on the list.